Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan - Fujii, Takayuki; Hagihara, Masao; Mitamura, Keiko; Nakashima, Shiori; Ohara, Shin; Uchida, Tomoyuki; Inoue, Morihiro; Okuda, Moe; Yasuhara, Atsuhiro; Murakami, Jurika; Duong, Calvin; Iwatsuki-Horimoto, Kiyoko; et al. (Internal Medicine, 2022)
Keywords: Adult; Antibodies, Viral; Coronaviruses; COVID-19; Hematologic Diseases - complications; Hematologic Diseases - epidemiology; Hematological diseases; Hematology; Humans; Immunoglobulin G; Immunoglobulin M; Internal medicine; Japan - epidemiology; Original; Retrospective Studies; Risk groups; Rituximab; SARS-CoV-2; SARS-CoV-2 IgG antibodies; Severe acute respiratory syndrome coronavirus 2; Spike protein; Japan; COVID-19; SARS-CoV-2 IgG antibodies; SARS-CoV-2